Inovio Pharma (INO) Misses Q3 EPS by 14c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.29 --0%
EPS Growth %: +75.9%
Financial Fact:
License fee and milestone revenue: 2.33M
Today's EPS Names:
ESP, VIVO, NEOV, More
EPS Growth %: +75.9%
Financial Fact:
License fee and milestone revenue: 2.33M
Today's EPS Names:
ESP, VIVO, NEOV, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q3 EPS of ($0.39), $0.14 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $9.36 million.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- AutoZone beats profit view but misses on revenue
- Getty Realty (GTY) Reiterated at Market Outperform by Citizens on Investment Volumes
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
